ECSP078043A - Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona - Google Patents
Derivados de benzofurarona como moduladores no esteroides de receptores de progesteronaInfo
- Publication number
- ECSP078043A ECSP078043A EC2007008043A ECSP078043A ECSP078043A EC SP078043 A ECSP078043 A EC SP078043A EC 2007008043 A EC2007008043 A EC 2007008043A EC SP078043 A ECSP078043 A EC SP078043A EC SP078043 A ECSP078043 A EC SP078043A
- Authority
- EC
- Ecuador
- Prior art keywords
- benzofurarona
- derivatives
- therapy
- progesterone receptors
- prevention
- Prior art date
Links
- 102000003998 progesterone receptors Human genes 0.000 title 1
- 108090000468 progesterone receptors Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 239000002379 progesterone receptor modulator Substances 0.000 abstract 2
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 238000002657 hormone replacement therapy Methods 0.000 abstract 1
- 201000010260 leiomyoma Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 201000007954 uterine fibroid Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Abstract
La presente invención se refiere a moduladores no esteroides del receptor de progesterona de la fórmula general I, al proceso para su producción, al uso de los moduladores del receptor de progesterona para la preparación de agentes farmacéuticos así como también composiciones farmacéuticas que contienen es-tos compuestos. Los compuestos según la invención son apropiados para la terapia y la prevención de enfermedades ginecológicas tales como endometrio-sis, leiomiomas de útero, hemorragias disfuncionales y dismenorrea y para la te-rapia y la prevención de tumores dependientes de hormonas y para el uso para el control de la fertilidad femenina y para la terapia de reemplazo hormonal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005030294A DE102005030294A1 (de) | 2005-06-24 | 2005-06-24 | Nichtsteroidale Progesteronrezeptor-Modulatoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP078043A true ECSP078043A (es) | 2008-01-23 |
Family
ID=36716643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2007008043A ECSP078043A (es) | 2005-06-24 | 2007-12-21 | Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1899315A1 (es) |
| JP (1) | JP2008543911A (es) |
| KR (1) | KR20080018275A (es) |
| CN (1) | CN101248056A (es) |
| AR (1) | AR057409A1 (es) |
| AU (1) | AU2006261049A1 (es) |
| BR (1) | BRPI0612305A2 (es) |
| CA (1) | CA2611900A1 (es) |
| CR (1) | CR9595A (es) |
| DE (1) | DE102005030294A1 (es) |
| DO (1) | DOP2006000150A (es) |
| EA (1) | EA200702604A1 (es) |
| EC (1) | ECSP078043A (es) |
| GT (1) | GT200600272A (es) |
| IL (1) | IL188022A0 (es) |
| MX (1) | MX2008000070A (es) |
| NO (1) | NO20080441L (es) |
| PE (1) | PE20070170A1 (es) |
| TW (1) | TW200738665A (es) |
| UY (1) | UY29626A1 (es) |
| WO (1) | WO2006136462A1 (es) |
| ZA (1) | ZA200800689B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30805A1 (es) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | Moduladores no esteroides de receptores de progesterona |
| DE102007032800A1 (de) * | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| TWI477276B (zh) | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
| BR112014029131B1 (pt) | 2012-05-31 | 2021-03-09 | Allergan Pharmaceuticals International Limited | cápsula de mucoadesivo |
| HK1211852A1 (en) | 2012-11-02 | 2016-06-03 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19723722A1 (de) * | 1997-05-30 | 1998-12-10 | Schering Ag | Nichtsteroidale Gestagene |
| US6358948B1 (en) * | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| HK1043788A1 (zh) * | 1999-05-04 | 2002-09-27 | American Home Products Corporation | 四環黃體酮受體調節劑化合物及方法 |
| WO2003059899A1 (en) * | 2002-01-14 | 2003-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| BR0308394A (pt) * | 2002-03-11 | 2005-01-25 | Schering Ag | 5-{2-hidróxi-3-[1-(3-trifluormetilfenil)-ciclopropil]-pr oprionilamino}-ftaleto e compostos relacionados com atividade moduladora de receptores de progesterona para uso em controle da fertilidade e terapia de reposição hormonal |
| DE10346939A1 (de) * | 2003-10-06 | 2005-05-19 | Schering Ag | Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
-
2005
- 2005-06-24 DE DE102005030294A patent/DE102005030294A1/de not_active Ceased
-
2006
- 2006-06-22 EA EA200702604A patent/EA200702604A1/ru unknown
- 2006-06-22 KR KR1020087001789A patent/KR20080018275A/ko not_active Withdrawn
- 2006-06-22 WO PCT/EP2006/006532 patent/WO2006136462A1/en not_active Ceased
- 2006-06-22 CA CA002611900A patent/CA2611900A1/en not_active Abandoned
- 2006-06-22 JP JP2008517445A patent/JP2008543911A/ja active Pending
- 2006-06-22 AU AU2006261049A patent/AU2006261049A1/en not_active Abandoned
- 2006-06-22 CN CNA2006800306699A patent/CN101248056A/zh active Pending
- 2006-06-22 BR BRPI0612305-8A patent/BRPI0612305A2/pt not_active Application Discontinuation
- 2006-06-22 MX MX2008000070A patent/MX2008000070A/es not_active Application Discontinuation
- 2006-06-22 EP EP06762405A patent/EP1899315A1/en not_active Withdrawn
- 2006-06-23 TW TW095122741A patent/TW200738665A/zh unknown
- 2006-06-26 PE PE2006000732A patent/PE20070170A1/es not_active Application Discontinuation
- 2006-06-26 GT GT200600272A patent/GT200600272A/es unknown
- 2006-06-26 DO DO2006000150A patent/DOP2006000150A/es unknown
- 2006-06-26 UY UY29626A patent/UY29626A1/es not_active Application Discontinuation
- 2006-06-27 AR ARP060102752A patent/AR057409A1/es unknown
-
2007
- 2007-12-10 IL IL188022A patent/IL188022A0/en unknown
- 2007-12-14 CR CR9595A patent/CR9595A/es not_active Application Discontinuation
- 2007-12-21 EC EC2007008043A patent/ECSP078043A/es unknown
-
2008
- 2008-01-23 ZA ZA200800689A patent/ZA200800689B/xx unknown
- 2008-01-23 NO NO20080441A patent/NO20080441L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008543911A (ja) | 2008-12-04 |
| GT200600272A (es) | 2007-08-20 |
| AU2006261049A1 (en) | 2006-12-28 |
| WO2006136462A1 (en) | 2006-12-28 |
| KR20080018275A (ko) | 2008-02-27 |
| UY29626A1 (es) | 2007-01-31 |
| CN101248056A (zh) | 2008-08-20 |
| EA200702604A1 (ru) | 2008-06-30 |
| NO20080441L (no) | 2008-03-07 |
| AR057409A1 (es) | 2007-12-05 |
| BRPI0612305A2 (pt) | 2010-11-03 |
| CA2611900A1 (en) | 2006-12-28 |
| EP1899315A1 (en) | 2008-03-19 |
| PE20070170A1 (es) | 2007-03-02 |
| TW200738665A (en) | 2007-10-16 |
| DE102005030294A1 (de) | 2007-01-04 |
| MX2008000070A (es) | 2008-03-19 |
| DOP2006000150A (es) | 2006-12-31 |
| CR9595A (es) | 2008-05-05 |
| ZA200800689B (en) | 2009-07-29 |
| IL188022A0 (en) | 2008-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20120175A7 (es) | Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos | |
| SV2010003580A (es) | Agonistas novedosos de los receptores de glucocorticoides | |
| ECSP18047708A (es) | Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparación | |
| ECSP078043A (es) | Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona | |
| EA201491096A1 (ru) | Производные 6,7-дигидро-5h-бензо[7]аннулена, способ их получения, фармацевтические препараты, которые их содержат, а также их применение для изготовления лекарственных средств | |
| CR20190379A (es) | Moduladores del receptor de estrógeno | |
| ECSP078044A (es) | Moduladores no esteroides de receptor de progesterona | |
| CR9627A (es) | Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof | |
| UY29625A1 (es) | Uso de moduladores no esteroides de receptores de progesterona | |
| UY30805A1 (es) | Moduladores no esteroides de receptores de progesterona | |
| SV2011003817A (es) | Derivados de estratrieno que comprenden bioisosteros heterociclicos para el anillo fenolico a | |
| ECSP067028A (es) | Profármacos de esteroides con acción androgénica | |
| UY30815A1 (es) | Moduladores no esteroidales del receptor de progesterona | |
| CU20100008A7 (es) | Estratrienos 8-beta sustituidos como estrógenos de acción selectiva | |
| CU20090109A7 (es) | Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides | |
| TH85615A (th) | สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์ | |
| TH85615B (th) | สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์ |